Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression-Reference-Cited by-同舟云学术

Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression

Published:2022-09 Issue:1 Volume:150 Page:21-30
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Arakawa Noriaki^ORCID,Matsuyama Shinichiro,Matsuoka Masaru,Kitamura Isao,Miyashita Keiko,Kitagawa Yutaro,Imai Kazuo,Ogawa Kumiko,Maeda Takuya,Saito Yoshiro,Hasegawa Chihiro

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference31 articles.

1. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis;Malik;BMJ Evid Based Med,2021

2. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases;Ishikawa;Respir Investig,2012

3. Serum KL-6 concentrations as a novel biomarker of severe COVID-19;d'Alessandro;J Med Virol,2020

4. Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia;Scotto;Int J Environ Res Publ Health,2021

5. Serial KL-6 measurements in COVID-19 patients;d'Alessandro;Intern Emerg Med,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presepsin in Critical Illness: Current Knowledge and Future Perspectives;Diagnostics;2024-06-20

2. A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning;Clinical Proteomics;2024-05-17

3. Plasma kallistatin levels in patients with COVID-19;Cukurova Medical Journal;2023-12-29

4. Variation in presepsin and thrombomodulin levels for predicting COVID-19 mortality;Scientific Reports;2023-12-06

5. A Reduced Proteomic Signature in Critically Ill Covid-19 Patients Determined With Plasma Antibody Micro-array and Machine Learning;2023-11-14